CoChat

Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement

Preece, Andrew F., Strahan, Karen M., Devitt, James, Yamamoto, Fumi-ichiro, Gustafsson, Kenth · 2002 · Blood
Cited by 66

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

No definitive biologic function has been associated with the human ABO histo-blood group polymorphism, or any other terminal carbohydrate differences within or between closely related species. We have experimentally addressed the question of whether viral particles can become glycosylated as determined by the glycosylation (eg, ABO) status of the producer cell and as a result be affected by human serum containing specific natural antibodies (NAbs). Measles virus was produced in cells transfected with cDNA encoding, either human A-transferase, B-transferase, an inactive “O-transferase,” or a pig α1-3galactosyltransferase (α1-3GT) synthesizing the Galα1-3Gal structure. The viruses were shown to carry the same ABO structures as the cells; that is, A but not B if produced in A-type cells, and B but not A if produced in B-type cells. Only O was detected on the virus produced from O-type cells, whereas reduced amounts of O appeared on the A- and B-type viral particles. In addition, the Galα1-3Gal structure was transferred onto measles only when grown in human cells expressing this structure. When subjected to human preimmune sera, the A-type, the B-type, and the Galα1-3Gal viral particles were partially neutralized in a complement-dependent manner. However, the O-type or the Galα1-3Gal–negative viral particles were not neutralized. The neutralization appeared to be mediated by specific NAb, as judged by specific inhibition using synthetic A and Galα1-3Gal oligosaccharides. Such viral glycosylation may thus partly explain why the ABO antigens and other similar intraspecies as well as interspecies polymorphic carbohydrates have evolved and been maintained over long evolutionary periods.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.v99.7.2477

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 44

  1. Blancher, 1997, The Rhesus system and its counterparts in nonhuman primates., 147, 10.1007/978-3-642-59086-3_6 · DOI
  2. Greenwell, 1997, Blood group antigens: molecules seeking a function?, Glycoconj J., 14, 159, 10.1023/A:1018581503164 · DOI · Paper page
  3. Haldane, 1949, Disease and evolution: symposium sui fattori ecologi e genetici della specilazione negli animali., Supplemento a la Ricerca Scientifica Anno 19., 19, 68
  4. Mourant, 1954, The Distribution of Human Blood Groups.
  5. Vogel, 1986, Human Genetics: Problems and Approaches., 10.1007/978-3-662-02489-8 · DOI · Paper page
  6. Gagneux, 1999, Evolutionary considerations in relating oligosaccharide diversity to biological function., Glycobiology., 9, 747, 10.1093/glycob/9.8.747 · DOI · Paper page
  7. Gustafsson, 1994, α1,3Galactosyltransferase: a target for in vivo genetic manipulation in xenotransplantation., Immunol Rev., 141, 59, 10.1111/j.1600-065X.1994.tb00872.x · DOI
  8. Boren, 1993, Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens., Sci., 262, 1892, 10.1126/science.8018146 · DOI · Paper page
  9. Springer, 1963, Influenza virus vaccine and blood group A-like substances., Transfusion., 3, 233
  10. Springer, 1964, Blood group A-like Forssman antigens in myxoviruses cultured in a chicken egg: their possible pathogenetic significance in vaccines., Klin Wochenschr., 42, 821, 10.1007/BF01479140 · doi:10.1007/bf01479140
  11. Aho, 1980, ABO associated genetic determinant in H1N1 influenza., Tissue Antigens., 16, 310, 10.1111/j.1399-0039.1980.tb00311.x · doi:10.1111/j.1399-0039.1980.tb00311.x
  12. Naikhin, 1989, Indicators of collective immunity to influenza depending on the blood group and sex of the population., Vopr Virusol., 34, 419
  13. Arendrup, 1991, Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from group B or O donors., AIDS., 5, 441, 10.1097/00002030-199104000-00014 · DOI
  14. Carroll, 1998, The role of complement and complement receptors in induction and regulation of immunity., Annu Rev Immunol., 16, 545, 10.1146/annurev.immunol.16.1.545 · DOI · Paper page
  15. Thornton, 1994, Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes., J Immunol., 152, 1727, 10.4049/jimmunol.152.4.1727 · DOI · Paper page
  16. Ochsenbein, 1999, Control of early viral and bacterial distribution and disease by natural antibodies., Sci., 286, 2156, 10.1126/science.286.5447.2156 · DOI · Paper page
  17. Scheffel, 1979, Role of environment in the development of “natural” hemagglutinins in Minnesota miniature swine., Infect Immun., 26, 202, 10.1128/IAI.26.1.202-210.1979 · doi:10.1128/iai.26.1.202-210.1979
  18. Hammer, 1992, Development of preformed natural antibodies in gnotobiotic dogs and pigs, impact of food antigens on antibody specificity., Transplant Proc., 24, 707
  19. Takeuchi, 1996, Sensitisation of cells and retroviruses to human serum by alpha(1-3)galactosyltransferase., Nature., 379, 85, 10.1038/379085a0 · DOI · Paper page
  20. Rother, 1995, A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody., J Exp Med., 182, 1345, 10.1084/jem.182.5.1345 · DOI · Paper page
  21. Takeuchi, 1997, Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1–3)galactosylation., J Virol., 71, 6174, 10.1128/JVI.71.8.6174-6178.1997 · DOI
  22. Yamamoto, 1990, Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions., J Biol Chem., 265, 19257, 10.1016/S0021-9258(17)30652-X · DOI · Paper page
  23. Yamamoto, 1996, Amino acid residue at codon 268 determines both activity and nucleotide-sugar donor substrate specificity of human histo-blood group A and B transferases: in vitro mutagenesis study., J Biol Chem., 271, 10515, 10.1074/jbc.271.18.10515 · DOI
  24. Strahan, 1995, cDNA sequence and chromosome localization of pig α1,3galactosyltransferase., Immunogenetics., 41, 101, 10.1007/BF00182319 · DOI
  25. Sinitsyna, 1990, Further-attenuated measles vaccine: virus passages affect viral surface protein expression, immunogenicity and histopathology pattern in vivo., Res Virol., 141, 517, 10.1016/0923-2516(90)90084-V · doi:10.1016/0923-2516(90)90084-v
  26. Albrecht, 1981, Role of virus strain in conventional and enhanced measles plaque neutralization test., J Virol Methods., 3, 251, 10.1016/0166-0934(81)90062-8 · DOI · Paper page
  27. Prokop, 1969, Human Blood and Serum Groups.
  28. Nomi, 1988, You Are Your Blood Type.
  29. Gibson, 1973, IQ and ABO blood groups., Nature., 246, 498, 10.1038/246498a0 · DOI
  30. Beardmore, 1983, ABO genes are differentially distributed in socio-economic groups in England., Nature., 303, 522, 10.1038/303522a0 · doi:10.1038/303522a0
  31. Garratty, 1993, Do blood groups have a biological role?, 201, 10.1201/9781482293494 · doi:10.1201/9781482293494
  32. Berger, 1989, Relationship between infectious diseases and human blood type., Eur J Clin Microbiol Infect Dis., 8, 681, 10.1007/BF01963752 · doi:10.1007/bf01963752
  33. Muschel, 1966, Blood groups, disease, and selection., Bacteriol Rev., 30, 427, 10.1128/BR.30.2.427-441.1966 · doi:10.1128/br.30.2.427-441.1966
  34. Andersson, 1989, Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity., Carbohydr Res., 185, 211, 10.1016/0008-6215(89)80036-9 · doi:10.1016/0008-6215(89)80036-9
  35. Yang, 1992, Development of human ABO blood group A antigen on Escherichia coli Y1089 and Y1090., Immunol Cell Biol., 70, 411, 10.1038/icb.1992.54 · doi:10.1038/icb.1992.54
  36. Vogel, 1960, Über die populationsgenetik der ABO-blutgruppen. 2. Mitteilung. Genhaüfigkeit und epidemische erkrankunge., Acta Genet Statis Med., 10, 267
  37. Oriol, 1999, Major carbohydrate epitopes in tissues of domestic and African wild animals of potential interest for xenotransplantation research., Xenotransplantation., 6, 79, 10.1034/j.1399-3089.1999.00008.x · DOI
  38. Ravn, 2000, Tissue distribution of histo-blood group antigens., APMIS., 108, 1, 10.1034/j.1600-0463.2000.d01-1.x · DOI · Paper page
  39. Osterhaus, 2001, Catastrophes after crossing species barriers., Philos Trans R Soc Lond B Biol Sci., 356, 791, 10.1098/rstb.2001.0856 · DOI
  40. Osterhaus, 1988, Identification of virus causing recent seal deaths., Nature., 335, 20, 10.1038/335020a0 · doi:10.1038/335020a0
  41. Roelke-Parker, 1996, A canine distemper virus epidemic in Serengeti lions (Panthera leo)., Nature., 379, 441, 10.1038/379441a0 · DOI · Paper page
  42. Osterhaus, 1997, Morbillivirus in monk seal mass mortality., Nature., 388, 838, 10.1038/42163 · doi:10.1038/42163
  43. Chua, 2000, Nipah virus: a recently emergent deadly paramyxovirus., Sci., 288, 1432, 10.1126/science.288.5470.1432 · DOI · Paper page
  44. Galili, 1996, Augmentation of the in vitro immunogenicity of influenza virus hemagglutinin by the natural anti-Gal antibody., Vaccine., 14, 321, 10.1016/0264-410X(95)00189-8 · DOI

Cited by

See all 66

Metadata

Authors
Preece, A. F., Strahan, K. M., Devitt, J., Yamamoto, F.-I., & Gustafsson, K.
Affiliations
From the Molecular Immunology Unit, Institute of Child Health, University College London, United Kingdom, and The Burnham Institute, La Jolla, CA.
Venue
Blood
Published
2002-04-01
Volume
99
Issue
7
Pages
2477-2482
ISSN
  • 1528-0020
  • 0006-4971
Cited by
66
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.